Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation

BACKGROUND: In a recent phase III randomized control trial, delivering a focal radiotherapy (RT) boost to tumors visible on MRI was shown to improve disease-free survival and regional/distant metastasis-free survival for patients with prostate cancer—without increasing toxicity. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Allison Y., Lui, Asona J., Katz, Matthew S., Berlin, Alejandro, Kamran, Sophia C., Kishan, Amar U., Murthy, Vedang, Nagar, Himanshu, Seible, Daniel, Stish, Bradley J., Tree, Alison C., Seibert, Tyler M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638743/
https://www.ncbi.nlm.nih.gov/pubmed/37950310
http://dx.doi.org/10.1186/s13014-023-02375-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638743/
https://www.ncbi.nlm.nih.gov/pubmed/37950310
http://dx.doi.org/10.1186/s13014-023-02375-5

Ejemplares similares